Release Date: February 20, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide more color on the offsets in contract structures, especially in light of potential reductions in headcount at the government? A: David Guilmette, CEO: Tariffs don't directly impact us as we're not in the manufacturing business. Regarding layoffs for Fed employees, our exposure to the public sector is not significant. Even under a worst-case scenario, the impact on revenue and earnings in 2025 would be immaterial.
Q: How are you thinking about capital allocation, especially with the stock at current levels? A: Jeremy Heaton, CFO: We're pleased with the dividend and will be opportunistic with share buybacks. The $200 million increase in authorization reflects our view of the company's value.
Q: Can you discuss the pacing of the 200 basis point headwind from runoffs in '23 over the course of '25? A: Jeremy Heaton, CFO: The impact hits January 1, affecting the entire year. However, as we progress through the year, new ARR wins will build into the revenue profile, leading to growth in the second half.
Q: What are the assumptions for back half revenue growth this year? A: Jeremy Heaton, CFO: The growth will depend on the timing and mix of ARR bookings in 2025 and project revenue. We expect less volatility in project revenue in the second half, driven by the enrollment process.
Q: Can you elaborate on the improvements in retention and the potential for further improvement? A: David Guilmette, CEO: We had historically high losses in 2023, but retention improved by 8 points this year. There's still room for improvement. We've stabilized our technology platform and made leadership changes to enhance client management and service delivery.
Q: How are you managing the balance between new bookings and cross-selling to current customers? A: David Guilmette, CEO: We have significant opportunities in areas like leaves and health administration. Our pipeline for 2025 looks promising, and we have dedicated teams for new logos and existing client expansions.
Q: How did the supplementary retiree health policies perform in Q4, and what do you expect for 2025? A: Jeremy Heaton, CFO: The business performed well and in line with expectations. We don't anticipate any onetime items affecting this business moving forward.
Q: Can you benchmark the contract renewal rate improvement against historical levels? A: David Guilmette, CEO: The 8-point improvement brings us close to historical levels. While there's always some pricing compression, we're not seeing anything out of the ordinary.
Q: Has the buyer checklist changed, especially with rising premiums? A: David Guilmette, CEO: Employers focus on the value we bring in helping participants engage with available programs, impacting the total cost of benefits. Our value proposition is more about impacting the overall spend rather than just our service fees.
Q: Is 2025 a higher renewal year compared to last year? A: David Guilmette, CEO: 2024 was a bit higher in terms of renewals. Typically, about one-fourth of the business is up for renewal each year, and this year will be slightly lower.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.